[go: up one dir, main page]

WO2002000891A3 - Human napsin-like aspartyl protease - Google Patents

Human napsin-like aspartyl protease Download PDF

Info

Publication number
WO2002000891A3
WO2002000891A3 PCT/EP2001/007000 EP0107000W WO0200891A3 WO 2002000891 A3 WO2002000891 A3 WO 2002000891A3 EP 0107000 W EP0107000 W EP 0107000W WO 0200891 A3 WO0200891 A3 WO 0200891A3
Authority
WO
WIPO (PCT)
Prior art keywords
aspartyl protease
human napsin
napsin
human
reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/007000
Other languages
French (fr)
Other versions
WO2002000891A2 (en
Inventor
Shyam Ramakrishnan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to AU2001267548A priority Critical patent/AU2001267548A1/en
Publication of WO2002000891A2 publication Critical patent/WO2002000891A2/en
Publication of WO2002000891A3 publication Critical patent/WO2002000891A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Reagents which regulate human napsin-like aspartyl protease activity and reagents which bind to human napsin-like aspartyl protease gene products can be used to treat cancer and osteoporosis.
PCT/EP2001/007000 2000-06-26 2001-06-21 Human napsin-like aspartyl protease Ceased WO2002000891A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001267548A AU2001267548A1 (en) 2000-06-26 2001-06-21 Regulation of human napsin-like aspartyl protease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21401000P 2000-06-26 2000-06-26
US60/214,010 2000-06-26

Publications (2)

Publication Number Publication Date
WO2002000891A2 WO2002000891A2 (en) 2002-01-03
WO2002000891A3 true WO2002000891A3 (en) 2002-04-11

Family

ID=22797423

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/007000 Ceased WO2002000891A2 (en) 2000-06-26 2001-06-21 Human napsin-like aspartyl protease

Country Status (2)

Country Link
AU (1) AU2001267548A1 (en)
WO (1) WO2002000891A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20081135A1 (en) 2008-06-24 2009-12-25 Trapani Paolo Di LIGHTING DEVICE

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022597A2 (en) * 1996-11-20 1998-05-28 Oklahoma Medical Research Foundation Cloning and characterization of napsin, an aspartic protease
WO2000004137A1 (en) * 1998-07-16 2000-01-27 Incyte Pharmaceuticals, Inc. Human aspartic proteases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022597A2 (en) * 1996-11-20 1998-05-28 Oklahoma Medical Research Foundation Cloning and characterization of napsin, an aspartic protease
WO2000004137A1 (en) * 1998-07-16 2000-01-27 Incyte Pharmaceuticals, Inc. Human aspartic proteases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL EBI; 6 January 2000 (2000-01-06), NATIONAL CANCER INSTITUTE, CANCER GENOME ANATOMY PROJECT (CGAP): "Homo sapiens cDNA clone similar to napsin 1 precursor", XP002188681 *

Also Published As

Publication number Publication date
WO2002000891A2 (en) 2002-01-03
AU2001267548A1 (en) 2002-01-08

Similar Documents

Publication Publication Date Title
AU2001269742A1 (en) Method of treating gastrointestinal diseases associated with species of genus clostridium
WO2002049593A3 (en) Use of dna repair enzymes as mmp-1 inhibitors
WO2001058275A3 (en) Use of acid-stable subtilisin proteases in animal feed
AU7961401A (en) Subtilase enzymes
AU2002237274A1 (en) Assay method, tnf modulator and its use
WO2001083513A3 (en) Antisense modulation of inhibitor of dna binding-1 expression
WO2002000891A3 (en) Human napsin-like aspartyl protease
WO2001088137A3 (en) Human myd88 adapter-like protein and functional fragments thereof
AU6424501A (en) Novel enzyme gene and its expression product
AU2001264245A1 (en) Novel enzyme gene and its expression product
AU2001292326A1 (en) Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like
WO2002000853A3 (en) Regulation of human caspase-1-like protease
AU2002252773A1 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
WO2002081705A3 (en) Regulation of human gnat acetyltransferase-like protein
WO2002052016A3 (en) Regulation of human protein l-isoaspartate o-methyltransferase-like enzyme
WO2002051996A3 (en) Regulation of human cyclophilin-like protein
WO2003099863A3 (en) Resistin binding proteins, their preparation and use
AU2002221624A1 (en) Human e3 ubiquitin protein ligase-like enzyme
AU2001266665A1 (en) Process for propagation and utilization of mimosa
AU2001257008A1 (en) Treating t-cell mediated diseases by modulating dr6 activity
WO2002006454A3 (en) Regulation of human carboxylesterase-like enzyme
WO2002018552A3 (en) Regulation of human aminotransferase-like enzyme
WO2002018567A3 (en) Regulation of human aminotransferase-like enzyme
WO2002026945A3 (en) Regulation of human aminotransferase-like enzyme
WO2002030969A3 (en) Regulation of human carboxylesterase-like enzyme

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP